IL-7R alpha/CD127 Antibody (22F3D9) [Allophycocyanin/Cy7]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-22376APCCY7
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry, Western Blot
Label
Allophycocyanin/Cy7 (Excitation = 650;755 nm, Emission = 767 nm)
Antibody Source
Monoclonal Mouse IgG2b Lambda Clone # 22F3D9
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Amino acids 141-237 of human CD127 were used as the immunogen for the antibody.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2b Lambda
Applications for IL-7R alpha/CD127 Antibody (22F3D9) [Allophycocyanin/Cy7]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark. Do not freeze.
Background: IL-7R alpha/CD127
Long Name
Interleukin 7 Receptor alpha
Alternate Names
CD127, IL-7 R alpha, IL-7Ra, IL7R, IL7R alpha
Gene Symbol
IL7R
Additional IL-7R alpha/CD127 Products
Product Documents for IL-7R alpha/CD127 Antibody (22F3D9) [Allophycocyanin/Cy7]
Product Specific Notices for IL-7R alpha/CD127 Antibody (22F3D9) [Allophycocyanin/Cy7]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...